X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (98) 98
index medicus (62) 62
humans (56) 56
female (43) 43
male (42) 42
aged (37) 37
middle aged (34) 34
adult (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
cancer (26) 26
colorectal cancer (26) 26
colorectal neoplasms - drug therapy (22) 22
chemotherapy (20) 20
camptothecin - analogs & derivatives (18) 18
colorectal neoplasms - pathology (17) 17
pharmacology & pharmacy (17) 17
colorectal neoplasms - genetics (16) 16
treatment outcome (16) 16
article (14) 14
genotype (14) 14
irinotecan (13) 13
prognosis (13) 13
aged, 80 and over (12) 12
bevacizumab (12) 12
medicine & public health (12) 12
camptothecin - therapeutic use (11) 11
fluorouracil (11) 11
fluorouracil - therapeutic use (11) 11
leucovorin - therapeutic use (11) 11
metastasis (11) 11
polymorphism, single nucleotide (11) 11
disease-free survival (10) 10
expression (10) 10
fluorouracil - administration & dosage (10) 10
gastric cancer (10) 10
neoplasm metastasis (10) 10
therapy (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
care and treatment (9) 9
japan (9) 9
oxaliplatin (9) 9
patients (9) 9
polymorphisms (9) 9
1st-line treatment (8) 8
analysis (8) 8
camptothecin - administration & dosage (8) 8
camptothecin - adverse effects (8) 8
fluorouracil - adverse effects (8) 8
glucuronosyltransferase - genetics (8) 8
kaplan-meier estimate (8) 8
leucovorin - administration & dosage (8) 8
leucovorin - adverse effects (8) 8
pharmacokinetics (8) 8
pharmacology/toxicology (8) 8
research (8) 8
retrospective studies (8) 8
survival (8) 8
antimitotic agents (7) 7
antineoplastic agents (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
asian continental ancestry group (7) 7
cetuximab (7) 7
colon-cancer (7) 7
colorectal carcinoma (7) 7
colorectal neoplasms - mortality (7) 7
genetic aspects (7) 7
neoplasm staging (7) 7
neoplasms - drug therapy (7) 7
trial (7) 7
angiogenesis (6) 6
antineoplastic agents - therapeutic use (6) 6
cancer patients (6) 6
cell lung-cancer (6) 6
cetuximab - administration & dosage (6) 6
dose-response relationship, drug (6) 6
genetic association studies (6) 6
metastases (6) 6
organoplatinum compounds - therapeutic use (6) 6
single-nucleotide polymorphism (6) 6
stomach cancer (6) 6
cell biology (5) 5
colon cancer (5) 5
drug combinations (5) 5
drug therapy (5) 5
folfoxiri (5) 5
gene (5) 5
genetics & heredity (5) 5
growth-factor receptor (5) 5
hematology, oncology and palliative medicine (5) 5
japanese (5) 5
liver neoplasms - secondary (5) 5
medical research (5) 5
metastatic colorectal cancer (5) 5
organoplatinum compounds - administration & dosage (5) 5
organoplatinum compounds - adverse effects (5) 5
polymorphism (5) 5
polymorphism, genetic (5) 5
research paper (5) 5
single nucleotide polymorphisms (5) 5
sn-38 (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 11/2018, Volume 45, Issue 11, pp. 1602 - 1607
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 11/2018, Volume 45, Issue 11, pp. 1602 - 1607
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 11/2018, Volume 45, Issue 11, p. 1602
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 541 - 541
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2016, Volume 34, Issue 4, pp. 404 - 404
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2016, Volume 34, Issue 4, pp. 237 - 237
Conference Proceeding
Investigational New Drugs, ISSN 0167-6997, 2/2014, Volume 32, Issue 1, pp. 104 - 112
Journal Article
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 2/2016, Volume 33, Issue 2, pp. 269 - 282
Journal Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, ISSN 0368-2811, 03/2019, Volume 49, Issue 3, pp. 210 - 227
Cooperative groups plays important roles in investigator-initiated clinical trials necessary to progress of chemotherapy. We reviewed active cooperative groups... 
LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | PERIOPERATIVE CHEMOTHERAPY | gastric cancer | HIGH-DOSE METHOTREXATE | RANDOMIZED-TRIAL | chemotherapy | MESSENGER-RNA LEVELS | GASTROESOPHAGEAL JUNCTION CANCER | PHASE-II TRIAL | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | co-operative group | S-1 PLUS CISPLATIN
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2008, Volume 31, Issue 11, pp. 2137 - 2142
ATP-binding cassette, sub-family C, number 2 (ABCC2) is involved in the biliary excretion of irinotecan and its metabolites, SN-38 and SN-38 glucuronide.... 
multidrug-resistance protein 2 | SN-38 | irinotecan | biliary excretion | systemic exposure | Biliary excretion | Irinotecan | Systemic exposure | Multidrug-resistance protein 2 | CPT-11 | GLUCURONIDATION | ORGANIC ANION-TRANSPORTER | UGT1A1-ASTERISK-6 | BILIARY-EXCRETION MECHANISMS | REGION | CELL LUNG-CANCER | GENE | METABOLITE SN-38 | PHARMACOLOGY & PHARMACY | SINGLE NUCLEOTIDE POLYMORPHISMS | Haplotypes | Inactivation, Metabolic | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fluorouracil - therapeutic use | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Leucovorin - therapeutic use | Multidrug Resistance-Associated Proteins - genetics | Camptothecin - analogs & derivatives | Camptothecin - pharmacokinetics | Camptothecin - adverse effects | Camptothecin - therapeutic use | Drug Administration Schedule | Japan | Genotype | Leucovorin - pharmacokinetics | Linkage Disequilibrium | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Polymorphism, Single Nucleotide | Infusions, Intravenous | Colorectal Neoplasms - pathology | Fluorouracil - pharmacokinetics | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 77, pp. 13 - 20
Abstract Purpose The most frequent bevacizumab-related side-effects are hypertension, proteinuria, bleeding and thromboembolism. To date, there is no biomarker... 
Hematology, Oncology and Palliative Medicine | Hypertension | Single-nucleotide polymorphism | Bevacizumab-associated toxicity | FOLFIRI/bevacizumab | Autophagy | Colorectal cancer | APOPTOSIS | INHIBITION | ONCOLOGY | SENESCENCE | STRESS | PLUS BEVACIZUMAB | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Middle Aged | Genotype | Male | Neoplasm Metastasis | Protein-Tyrosine Kinases - genetics | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - drug therapy | Hypertension - chemically induced | Polymorphism, Single Nucleotide - genetics | Adult | Camptothecin - administration & dosage | Cetuximab - administration & dosage | Female | Aged | Autophagy - genetics | Chemotherapy, Adjuvant | Camptothecin - analogs & derivatives | Genetic aspects | Metastasis | Single nucleotide polymorphisms | Thromboembolism | Vascular endothelial growth factor | Medicine, Preventive | Preventive health services | Measurement | Endothelial growth factors | Blood pressure | Toxicity | Genes | Colorectal carcinoma | Clinical trials | Patients | Two phase | Bleeding | Bevacizumab | Metastases | Confidence intervals | Angiogenesis | Alleles | Phagocytosis | Genotypes | Polymorphism | Proteinuria | Cancer | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2017, Volume 141, Issue 6, pp. 1222 - 1230
The TLR7 and TLR9 signalings are implicated in the regulation of the immune system through type‐I interferon induction. Preclinical studies have demonstrated... 
cetuximab | metastatic colorectal cancer | polymorphism | TLR7 | predictive marker | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ANTIBODY | IFN-ALPHA PRODUCTION | RECEPTOR 7 | PLASMACYTOID DENDRITIC CELLS | SEX-SPECIFIC ASSOCIATION | IMMUNE | THERAPY | ONCOLOGY | INFLAMMATION | INDEPENDENTLY CONTRIBUTE | Leucovorin - administration & dosage | Predictive Value of Tests | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | RNA, Messenger - biosynthesis | Clinical Trials, Phase III as Topic | Neoplasm Metastasis | Fluorouracil - administration & dosage | Multicenter Studies as Topic | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Toll-Like Receptor 7 - genetics | Toll-Like Receptor 7 - biosynthesis | RNA, Messenger - genetics | Randomized Controlled Trials as Topic | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cetuximab - administration & dosage | Aged | Polymorphism, Single Nucleotide | Colorectal Neoplasms - pathology | Clinical Trials, Phase II as Topic | Cancer patients | Care and treatment | Chemotherapy | Analysis | Colorectal cancer | Genetic aspects | Interferon | Single nucleotide polymorphisms | Metastasis | Biological response modifiers | Chromosomes | Cancer | Colorectal carcinoma | Single-nucleotide polymorphism | K-Ras protein | Bevacizumab | Metastases | Gene sequencing | Anticancer properties | Toll-like receptors | Deoxyribonucleic acid--DNA | Immune system | Killing | TLR7 protein | Immunomodulation | Genetic diversity | Patients | TLR9 protein | Polymerase chain reaction | Interferon regulatory factor 7 | Studies | Antitumor activity | Death | DNA sequencing | Polymorphism | Index Medicus
Journal Article
20.